Cart
sales@molnova.com
Zomepirac Sodium
CAS No. 64092-48-4
Zomepirac Sodium( —— )
Catalog No. M15437 CAS No. 64092-48-4
Zomepirac, formerly marketed as Zomax tablets, was associated with fatal and near-fatal anaphylactoid reactions.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 26 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameZomepirac Sodium
-
NoteResearch use only, not for human use.
-
Brief DescriptionZomepirac, formerly marketed as Zomax tablets, was associated with fatal and near-fatal anaphylactoid reactions.
-
DescriptionZomepirac, formerly marketed as Zomax tablets, was associated with fatal and near-fatal anaphylactoid reactions.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE2
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number64092-48-4
-
Formula Weight313.71
-
Molecular FormulaC15H13ClNNaO3
-
Purity>98% (HPLC)
-
SolubilityWater: 0.026 mg/mL
-
SMILES[Na+].CN1C(CC([O-])=O)=CC(C)=C1C(=O)C1=CC=C(Cl)C=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Hata AN, et al. Mol Pharmacol. 2005 Mar;67(3):640-7.
molnova catalog
related products
-
PDE5-IN-9
PDE5-IN-9 inhibits Phosphodiesterase PDE1c and is used to treat hypertension, heart failure, myocardial infarction, kidney failure, asthma, bronchitis, and dementia.
-
AZD1283
AZD1283 is an effective P2Y12 receptor antagonist (EC50: 3.0 ug/kg/min, binding IC50: 11 nM).
-
Darutigenol
Darutigenol has obvious antithrombotic effect, its mechanism may be related to inhibition of platelet aggregation and adhesion.
